Reminder - Allos Therapeutics to Hold Q2 2004 Financial Results Conference Call and Webcast on Tuesday, August 3
03 Août 2004 - 2:45PM
PR Newswire (US)
Reminder - Allos Therapeutics to Hold Q2 2004 Financial Results
Conference Call and Webcast on Tuesday, August 3 WESTMINSTER,
Colo., Aug. 3 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc.
(NASDAQ:ALTH) will hold a conference call Tuesday, August 3, 2004,
at 4:30 PM ET to discuss its second quarter 2004 financial results.
Time: 4:30 PM ET Date: Tuesday, August 3, 2004 Dial-in: (800)
310-1961 / (719) 457-2692 international Webcast:
http://www.allos.com/ (homepage and investor relations section)
Interested parties unable to participate in the live conference
call may access a recorded rebroadcast by dialing 888-203-1112, or
+1-719-457-0820 for international callers; the pass code number is
133938. The replay will be available from 7:30 p.m. ET on Tuesday,
August 3, 2004 until 12:59 AM ET on August 10, 2004. In addition,
the webcast will be archived for on-demand listening for 30 days at
http://www.allos.com/. About Allos Therapeutics, Inc. Allos
Therapeutics, Inc. is a biopharmaceutical company focused on
developing and commercializing innovative drugs for improving
cancer treatments. The company's lead clinical candidate, RSR13
(efaproxiral), is a synthetic small molecule that has the potential
to sensitize hypoxic (oxygen deprived) tumor tissues and enhance
the efficacy of standard radiation therapy. In addition, Allos is
developing PDX, an injectable small molecule chemotherapeutic agent
that has a superior potency and toxicity profile relative to
methotrexate and other dihydrofolate reductase, or DHFR,
inhibitors. For more information, please visit the company's web
site at: http://www.allos.com/. DATASOURCE: Allos Therapeutics,
Inc. CONTACT: Media, Jennifer Neiman, Corporate Communications of
Allos Therapeutics, Inc., +1-720-540-5227, ; or Investors, Fern
Lazar of Lazar Partners Limited, +1-212-867-1762, , for Allos
Therapeutics, Inc. Web site: http://www.allos.com/
Copyright
Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Allos Therapeutics, Inc. (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Allos Therapeutics (MM)